All POIA recommendations are being addressed by HHS, with the majority of recommendations being addressed through dedicated cross-agency collaboration. Of the 39 recommendations, the Administration for Children and Families (ACF) is addressing 15, the Agency for Healthcare Research and Quality (AHRQ) is addressing two, the Centers for Disease Control and Prevention (CDC) is addressing 26, the Centers for Medicare & Medicaid Services (CMS) is addressing 21, the Food and Drug Administration is addressing seven, the Health Resources and Services Administration (HRSA) is addressing 29, Indian Health Services (IHS) is addressing 29, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is addressing 14, the National Institute on Drug Abuse (NIDA) is addressing 18, HHS's Office of the Assistant Secretary for Health (OASH) is addressing 14, and the Substance Abuse and Mental Health Services Administration (SAMHSA) is addressing 25.
All agency activities are listed in the tables below. Updates are listed by recommendations, which in turn are organized into functional categories (Systemic, Clinical, Data and Surveillance, and Research and Evaluation).
Examples of Cross-Agency Collaboration
As highlighted above, the majority of recommendations are addressed through cross-agency collaboration with dedicated cross-agency activities for 36 of the 39 recommendations. For instance, ACF and SAMHSA jointly fund the National Center on Substance Abuse and Child Welfare (NCSACW) -- a technical assistance and training resource -- to improve family recovery, safety, and stability by advancing practices and collaboration among agencies, organizations, and courts working with families affected by substance use and co-occurring mental disorders and child abuse or neglect. ACF/Administration on Children, Youth and Families (ACYF) and SAMHSA also conducted a Policy Academy entitled "Improving Outcomes for Pregnant and Postpartum Women with Opioid Use Disorders, and their Infants and Families" on February 7-8, 2017, in Baltimore, MD to develop action plans on the complex needs of pregnant and parenting women. CMS and HRSA jointly issued guidance regarding Coverage of Maternal, Infant, and Early Childhood Home Visiting Services. NICHD (Office of the Director, Institutional Development Awards [IDeA] States Pediatric Clinical Trial Network) and NIDA partner on multiple research projects, including the "ACT NOW: Advancing Clinical Trials in NOWs" Initiative to evaluate treatment options and improve clinical care of infants with NAS. SAMHSA leads several joint efforts, including a work group entitled "Children and Families Impacted by the Opioid Crisis," a cross-agency collaboration with the Maternal and Child Health Bureau/HRSA, OASH/OWH, NIDA, and ACF in collaboration with CDC. OASH/OWH and IHS partnered to address opioid misuse among women of reproductive age in the American Indian/Alaskan Native (AI/AN) communities. OASH/OWH is also partnering with the HRSA Office of Women's Health on an initiative to produce a care coordination model for women impacted by opioids who receive healthcare services via HRSA-administered programs.